Personalized medicine is the future of medicine. It will become standard in every hospital, clinic, and medical practice, supported by electronic records, decision support systems, and tests that analyze disease for specific genetic markers.
Traditionally, the pharmaceutical R&D path has involved testing large numbers of patients to evaluate the therapeutic effect of a molecule; now companies are narrowing their focus and determining mutations and genomics of diseases through companion diagnostics and biomarkers. Companies are interested in discovering and developing medicines that are much more targeted and personalized to specific…
Four Steps to Integrating Prescription and Device Commercial Strategies
Precision vs. Personalized Medicine
Physicians Not Ready for Impact of Personalized Medicine, But Patients Are